Skip to main content
. Author manuscript; available in PMC: 2009 Oct 6.
Published in final edited form as: Clin Infect Dis. 2009 Apr 1;48(7):940–950. doi: 10.1086/597354

Table 1.

Baseline characteristics of the study patients.

Characteristic No. (%) of patients
Clinical model
(n = 1679)
CD4
cell count
model
(n = 1663)
CD4
cell count and
HIV RNA level
model
(n = 1231)
Age, years
  ≥40 693 (41.27) 688 (41.37) 571 (46.39)
  30–39 767 (45.68) 760 (45.70) 538 (43.70)
  ≤29 219 (13.04) 215 (12.93) 122 (9.91)
Sex
  Male 1207 (71.89) 1199 (72.10) 907 (73.68)
  Female 472 (28.11) 464 (27.90) 324 (26.32)
Mode of HIV transmission
  Heterosexual sex 1217 (72.48) 1203 (72.34) 816 (66.29)
  IDU 74 (4.41) 72 (4.33) 44 (3.57)
  MSM 310 (18.46) 310 (18.64) 304 (24.70)
  Other 78 (4.65) 78 (4.69) 67 (5.44)
ART status before HAART initiation
  Naive 1351 (80.46) 1336 (80.34) 935 (75.95)
  Experienced 328 (19.54) 327 (19.66) 296 (24.05)
Previous AIDS-defining illness
  No 830 (49.43) 821 (49.37) 630 (51.18)
  Yes 849 (50.57) 842 (50.63) 601 (48.82)
BMI category
  ≤18 195 (16.74) 192 (11.55) 114 (9.26)
  >18 to 25 1203 (71.65) 1191 (71.62) 897 (72.87)
  >25 281 (16.74) 280 (16.84) 220 (17.87)
ART status
  Not receiving ART 51 (3.04) 51 (3.07) 39 (3.17)
  Receiving ART 1628 (96.96) 1612 (96.93) 1192 (96.83)
Anemia
  None 855 (50.92) 854 (51.35) 734 (59.63)
  Mild 797 (47.47) 783 (47.08) 490 (39.81)
  Severe 27 (1.61) 26 (1.56) 7 (0.57)
ALT level, IU/L
  Normal 1664 (99.11) 1647 (99.04) 1223 (99.35)
  Abnormal 15 (0.89) 16 (0.96) 8 (0.65)
CD4 cell count, cells/µL
  ≤50 135 (8.12) 44 (3.57)
  51–200 431 (25.92) 257 (20.88)
  201–350 499 (30.01) 401 (32.58)
  >350 598 (35.96) 529 (42.97)
HIV load, copies/mL
  ≤500 934 (75.87)
  >500 297 (24.13)

NOTE. ALT, alanine aminotransferase; ART, antiretroviral treatment; BMI, body mass index (calculated as the weight in kilograms divided by the square of the height in meters); IDU, injection drug use; MSM, men who have sex with men.